Bernard Man Yung Cheung

Author

University of Hong Kong ORCID

Also Known As

Bernard Man Yung CHEUNG, Bernard Man Yung Cheung, Bernard Man- Yung Cheung, Cheung, Bernard Man Yung

144

Publications

Citations

H-Index

Concepts

All Affiliations

University of Hong Kong Chinese University of Hong Kong Second Hospital of Tianjin Medical University Tianjin Medical University City University of Hong Kong

About

Bernard Man Yung Cheung is an author at University of Hong Kong specializing in medicine, cardiovascular disease, and public health.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	8	8	306
2	Public Health	5	5	118
3	Diabetes	3	3	79
4	Epidemiology	3	3	57
5	Health Informatics	1	1	12

Bernard Man Yung Cheung

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Continual Decrease in Blood Lead Level in Americans: United States National Health Nutrition and Examination Survey 1999-2014 Man Fung Tsoi, Ching‐Lung Cheung, Bernard Man Yung Cheung The American Journal of Medicine	2016	181
Safety of antiobesity drugs Bernard Man Yung Cheung, Nithushi Rajitha Samaranayake Therapeutic Advances in Drug Safety Drug SafetySafe Antiobesity DrugsAntiobesity DrugsCardiovascular DiseasePharmacoepidemiology	2013	159
Elevated Circulating Adipocyte‐Fatty Acid Binding Protein Levels Predict Incident Cardiovascular Events in a Community‐Based Cohort: A 12‐Year Prospective Study Wing Chow, Annette W.K. Tso, Aimin Xu, Journal of the American Heart Association	2013	98
Comparative cardiovascular risk in users versus non-users of xanthine oxidase inhibitors and febuxostat versus allopurinol users Chengsheng Ju, Rachel Wing Chuen Lai, Ka Hou Christien Li, Lara D. Veeken	2019	96
Long-term post-acute sequelae of COVID-19 infection: a retrospective, multi-database cohort study in Hong Kong and the UK Ivan Chun Hang Lam, Carlos King Ho Wong, Ran Zhang, EClinicalMedicine	2023	96
Deamidated Lipocalin‐2 Induces Endothelial Dysfunction and Hypertension in Dietary Obese Mice Erfei Song, Bosheng Huang, Han‐Bing Deng, Journal of the American Heart Association	2014	72
Blood lead level and risk of hypertension in the United States National Health and Nutrition Examination Survey 1999–2016 Man Fung Tsoi, Chris Wai Hang Lo, Bernard Man Yung Cheung Scientific Reports	2021	52
Comparison of Sodium-Glucose Cotransporter-2 Inhibitor and Dipeptidyl Peptidase-4 Inhibitor on the Risks of New-Onset Atrial Fibrillation, Stroke and Mortality in Diabetic Patients: A Propensity Score-Matched Study in Hong Kong Sharen Lee, Jiandong Zhou, Keith Sai Kit Leung, Cardiovascular Drugs and Therapy	2022	49
Development of a multivariable prediction model for severe COVID-19 disease: a population-based study from Hong Kong Jiandong Zhou, Sharen Lee, Xiansong Wang, npj Digital Medicine	2021	40
Lower risk of gout in sodium glucose cotransporter 2 (SGLT2) inhibitors versus dipeptidyl peptidase-4 (DPP4) inhibitors in type-2 diabetes Jiandong Zhou, Xuejin Liu, Oscar Hou In Chou, Lara D. Veeken	2022	37

Page 1